Related Experiment Video
Updated: Jul 6, 2026

3-D Imaging and Analysis of Neurons Infected In Vivo with Toxoplasma gondii
Published on: December 9, 2014
[A descriptive study of neurocysticercosis in a tertiary care hospital]
G Más-Sesé1, I Vives-Piñera, A Fernández-Barreiro
1Sección de Neurología, Hospital General Universitario de Elche, 03203 Elche, Espana. gemmasese@hotmail.com
Introduction:
Neurocysticercosis is the most frequent parasitic disease affecting the central nervous system. It is a disease that is endemic to certain countries in South America. The phenomenon of immigration, however, has increased its prevalence in developed regions due to the arrival of immigrants from endemic areas.
Aim:
To present the clinical and demographic characteristics of the cases of neurocysticercosis attended in a tertiary care hospital in the city of Murcia.
Patients And Methods:
We conducted a descriptive, retrospective study by reviewing the medical records of patients with a hospital diagnosis of neurocysticercosis over a nine-year period (1997-2005). Demographic and clinical data on these patients were collected.
Results:
Twenty-three patients (three under 12 years of age) were found. Mean age: 29.6 years. Countries of origin: Ecuador and Bolivia. The most frequently observed clinical manifestations were: epileptic seizures (73.9%), headache (39.1%) and neurological focus (26.1%). Albendazole was employed in 91.3% of cases and corticoids in 73.9%. The most frequently used drug in patients who received antiepileptic therapy was phenytoin. Four patients required surgical treatment. During the follow-up period, 52.8% of the patients were asymptomatic.
Conclusions:
Neurocysticercosis is a disease that is becoming increasingly more prevalent in Spain and we should suspect its presence in patients from endemic areas who visit because of clinical symptoms involving the central nervous system.
Related Concept Videos
Toxoplasmosis
Brain Abscess l: Introduction
Cryptococcal Meningitis
Amebiasis
American Trypanosomiasis
Aneurysm II: Clinical Manifestations and Diagnostic Studies
